October 15, 2026

Prenatal diet tied to colic with eczema

Lower Mediterranean diet adherence, greater dietary inflammation, and lower seafood intake during pregnancy were associated with higher odds of both conditions occurring together in infants.

MDSpire News

October 14, 2026

Skin odor signatures may shift with age

Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.

MDSpire News

October 13, 2026

Alopecia therapy gains FDA breakthrough status

The designation covers an investigational botanical treatment for moderate-to-severe alopecia areata in patients aged 2 years and older.

MDSpire News

October 12, 2026

CDC: Measles cases surpass 4,000 in 2026

CDC data show that 96% of cases are outbreak-associated, with adults accounting for 40% of cases, up from 29% in 2025.

MDSpire News

September 10, 2026

Medical Oddities: A fowl cause of urinary obstruction

A rogue chicken bone, stalled sweat, yoga for IBS, and L-theanine for sleep is break room fodder this week.

MDSpire News

August 31, 2026

Do antihistamines help atopic dermatitis?

First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.

MDSpire News

August 28, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

MDSpire News

August 27, 2026

10 states that support physician work-life balance

These 10 states have paid family or medical leave programs and health, wellness, peer support, or monitoring resources available to physicians or other health professionals.

MDSpire News

July 09, 2026

Connected Health May Match In-Person AD Care

A randomized clinical trial found that a team-based connected health model achieved equivalent improvements in atopic dermatitis severity and symptoms compared with conventional in-person care over 12 months.

MDSpire News

June 30, 2026

FDA Expands Pediatric Roflumilast Use

The expanded indication is supported by pharmacokinetic, safety, tolerability, exploratory efficacy, and long-term safety data from studies in children aged 2 to 5 years.

MDSpire News